Sotera Health SHC Sterigenics — Segment income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sotera Health in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sotera Health's sterigenics — segment income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sotera Health's sterigenics — segment income?
- Sotera Health (SHC) reported sterigenics — segment income of $96.41M in Q1 2026.
- How has Sotera Health's sterigenics — segment income changed year-over-year?
- Sotera Health's sterigenics — segment income increased by 9.6% year-over-year, from $88M to $96.41M.
- What is the long-term trend for Sotera Health's sterigenics — segment income?
- Over 3 years (2022 to 2025), Sotera Health's sterigenics — segment income has grown at a 6.8% compound annual growth rate (CAGR), from $339.14M to $412.89M.
- What does sterigenics — segment income mean?
- The operating profit generated by the Sterigenics segment after deducting segment-specific operating expenses from its net revenues. This serves as a primary indicator of the segment's profitability and its contribution to the overall corporate bottom line.